Page 3 - Les meilleurs doctors traitant la maladie suivante : Métastases dans le foie - TOP -85 des médecins

Le professeur Prof. Dr Klaus Kaczirek est un expert de premier plan en chirurgie endocrinienne et oncologique, spécialisé dans les interventions de la thyroïde, de la parathyroïde et des glandes surrénales.

• Plus de 30 ans d'expérience en chirurgie endocrinienne et viscérale
• Professeur de chirurgie à l'Université de médecine de Vienne
• Spécialisation dans les tumeurs neuroendocrines et les cancers produisant des hormones
• Nombreuses publications sur la biologie des tumeurs endocrines et les techniques mini-invasives

Le professeur agrégé Tahsin Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'hôpital universitaire Istinye Liv.

• Plus d'une décennie d'expérience en oncologie
• Travailler à la clinique d'oncologie d'Ankara et à l'hôpital régional de formation et de recherche d'Erzurum
• Nommer professeur agrégé en 2016

Le Prof. associé Nail Paksoy est spécialisé dans le traitement des métastases hépatiques à l'hôpital Medipol Bahçelievler, avec des recherches approfondies en oncologie.

• Certifié par l'ESMO en oncologie médicale
• Participation à de multiples essais cliniques internationaux pour les traitements du cancer
• Publication de nombreux articles sur les cancers métastatiques
• Formation spécialisée (Fellowship) à l'Institut d'oncologie de l'Université d'Istanbul

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le professeur Gul Alco allie plus de 25 ans d'expérience en oncologie radiothérapique à un leadership académique dans les meilleures universités turques.

• Spécialisé dans le traitement des métastases hépatiques par des techniques de radiation précises
• Professeur au département d'oncologie radiothérapique de l'université Medipol d'Istanbul
• Formé à l'université d'Istanbul – la principale faculté de médecine de Turquie
• Concilier la pratique clinique et l'enseignement aux futurs radio-oncologues

Spécialisé en chirurgie laparoscopique des métastases hépatiques – formé dans les meilleurs programmes de l'Université d'Istanbul.

• Plus de 30 ans d'expérience en chirurgie générale et laparoscopique
• Formation avancée en chirurgie laparoscopique bariatrique et oncologique
• Membre de l'Association Turque de Chirurgie

Spécialisé en oncologie médicale avec une formation à l'Université Akdeniz – le Dr Alemdar se concentre sur les métastases hépatiques au Medical Park Antalya.

• Formé en médecine interne avant de se spécialiser en oncologie
• Expérience dans plusieurs hôpitaux de premier plan, dont l'Université Akdeniz
• Poste actuel au complexe hospitalier Medical Park Antalya
• Membre d'associations professionnelles d'oncologie

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Plus de 30 ans de spécialisation en virothérapie – Le Dr Jaunalksne apporte des approches immunologiques de pointe pour traiter les métastases hépatiques à la Pallas Clinic.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne
• Se concentrer sur les traitements d'immunothérapie innovants

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le professeur Rifaat Safadi dirige l'unité des maladies du foie au centre médical Hadassah, se spécialisant dans les traitements hépatiques avancés avec une reconnaissance internationale.

• Formé auprès du professeur Scott Friedman à la Sinai School of Medicine de New York
• Membre d'associations internationales pour l'étude du foie
• Récompensé pour ses recherches sur la modulation immunitaire de la fibrose hépatique
• Auteur de nombreux articles en hépatologie
• Chef de l'unité des maladies du foie au centre médical Hadassah

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Spécialisé dans les chirurgies oncologiques complexes, y compris les métastases hépatiques, aux hôpitaux Büyük Anadolu.

• Expert en chirurgies du pancréas et des voies biliaires
• Compétent en chirurgies oncologiques et mammaires
• Expérimenté dans les interventions pour le cancer de l'estomac et du côlon
• Réaliser des chirurgies du cancer de la thyroïde et de l'obésité